UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation

Blood, 2020-05, Vol.135 (19), p.1619-1629

2020

Volltextzugriff (PDF)

Management of Respiratory Viral Infections in Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies

Clinical infectious diseases, 2014-11, Vol.59 (suppl_5), p.S344-S351

2014

Volltextzugriff (PDF)

Understanding the clinical significance of cytomegalovirus viremia after chimeric antigen receptor T-cell therapy: Should we be treating a value?

Clinical infectious diseases, 2024-02

2024

Volltextzugriff (PDF)

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

The New England journal of medicine, 2017-12, Vol.377 (25), p.2433-2444

2017

Volltextzugriff (PDF)

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

Clinical infectious diseases, 2011-02, Vol.52 (4), p.e56-e93

2011

Volltextzugriff (PDF)

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts

Annals of internal medicine, 2020-02, Vol.172 (4), p.229

2020

Volltextzugriff (PDF)

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

Blood, 2013-08, Vol.122 (7), p.1316-1324

2013

Volltextzugriff (PDF)

Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

Clinical infectious diseases, 2011-02, Vol.52 (4), p.427-431

2011

Volltextzugriff (PDF)

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

The New England journal of medicine, 2010-11, Vol.363 (22), p.2091-2101

2010

Volltextzugriff (PDF)

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy

Blood, 2004-03, Vol.103 (6), p.2003-2008

2004

Volltextzugriff (PDF)

Invasive Aspergillosis following Hematopoietic Cell Transplantation: Outcomes and Prognostic Factors Associated with Mortality

Clinical infectious diseases, 2007-02, Vol.44 (4), p.531-540

2007

Volltextzugriff (PDF)

Combination Antifungal Therapy for Invasive Aspergillosis

Clinical infectious diseases, 2004-09, Vol.39 (6), p.797-802

2004

Volltextzugriff (PDF)

Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients

Blood, 2011-11, Vol.118 (20), p.5689-5696

2011

Volltextzugriff (PDF)

Cytomegalovirus (CMV) Reactivation and CMV-Specific Cell-Mediated Immunity After Chimeric Antigen Receptor T-Cell Therapy

Clinical infectious diseases, 2024-04, Vol.78 (4), p.1022-1032

2024

Volltextzugriff (PDF)

Influenza Infections after Hematopoietic Stem Cell Transplantation: Risk Factors, Mortality, and the Effect of Antiviral Therapy

Clinical infectious diseases, 2004-11, Vol.39 (9), p.1300-1306

2004

Volltextzugriff (PDF)

Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease

The Journal of infectious diseases, 2014-04, Vol.209 (8), p.1195-1204

2014

Volltextzugriff (PDF)

Identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR

Clinical chemistry (Baltimore, Md.), 2014-05, Vol.60 (5), p.765-772

2014

Volltextzugriff (PDF)

Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT

Blood, 2012-10, Vol.120 (14), p.2796-2806

2012

Volltextzugriff (PDF)

Parainfluenza Virus Lower Respiratory Tract Disease After Hematopoietic Cell Transplant: Viral Detection in the Lung Predicts Outcome

Clinical infectious diseases, 2014-05, Vol.58 (10), p.1357-1368

2014

Volltextzugriff (PDF)

Respiratory Syncytial Virus Lower Respiratory Disease in Hematopoietic Cell Transplant Recipients: Viral RNA Detection in Blood, Antiviral Treatment, and Clinical Outcomes

Clinical infectious diseases, 2013-12, Vol.57 (12), p.1731-1741

2013

Volltextzugriff (PDF)

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

Blood, 2010-12, Vol.116 (24), p.5111-5118

2010

Volltextzugriff (PDF)

Predictive Value of Respiratory Viral Detection in the Upper Respiratory Tract for Infection of the Lower Respiratory Tract With Hematopoietic Stem Cell Transplantation

The Journal of infectious diseases, 2020-01, Vol.221 (3), p.379-388

2020

Volltextzugriff (PDF)

Toll-like Receptor 4 Polymorphisms and Aspergillosis in Stem-Cell Transplantation

The New England journal of medicine, 2008-10, Vol.359 (17), p.1766-1777

2008

Volltextzugriff (PDF)

Kinetics of Double-Stranded DNA Viremia After Allogeneic Hematopoietic Cell Transplantation

Clinical infectious diseases, 2018-01, Vol.66 (3), p.368-375

2018

Volltextzugriff (PDF)

1 – 25 von 390

Suche als RSS-Feed

Aktive Filter

KollektionPublisher website

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(271)
Mit Volltextzugriff
(365)

Publikationsform

Artikel
(390)

Sprache

Englisch
(390)
Japanisch
(85)

Erscheinungsjahr

n.n

Thema

Science & Technology
(246)
Life Sciences & Biomedicine
(244)
Humans
(242)
Adult
(159)
Male
(154)
Female
(153)
Immunology
(148)
Middle Aged
(145)
Hematology
(124)
Infectious Diseases
(117)
Transplantation
(103)
Microbiology
(96)
Adolescent
(94)
Biological And Medical Sciences
(93)
Medical Sciences
(92)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(86)
Child
(80)
Aged
(78)
Child, Preschool
(58)
Cytomegalovirus
(58)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation

Management of Respiratory Viral Infections in Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies

Understanding the clinical significance of cytomegalovirus viremia after chimeric antigen receptor T-cell therapy: Should we be treating a value?

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy

Invasive Aspergillosis following Hematopoietic Cell Transplantation: Outcomes and Prognostic Factors Associated with Mortality

Combination Antifungal Therapy for Invasive Aspergillosis

Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients

Cytomegalovirus (CMV) Reactivation and CMV-Specific Cell-Mediated Immunity After Chimeric Antigen Receptor T-Cell Therapy

Influenza Infections after Hematopoietic Stem Cell Transplantation: Risk Factors, Mortality, and the Effect of Antiviral Therapy

Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease

Identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR

Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT

Parainfluenza Virus Lower Respiratory Tract Disease After Hematopoietic Cell Transplant: Viral Detection in the Lung Predicts Outcome

Respiratory Syncytial Virus Lower Respiratory Disease in Hematopoietic Cell Transplant Recipients: Viral RNA Detection in Blood, Antiviral Treatment, and Clinical Outcomes

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

Predictive Value of Respiratory Viral Detection in the Upper Respiratory Tract for Infection of the Lower Respiratory Tract With Hematopoietic Stem Cell Transplantation

Toll-like Receptor 4 Polymorphisms and Aspergillosis in Stem-Cell Transplantation

A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients

Kinetics of Double-Stranded DNA Viremia After Allogeneic Hematopoietic Cell Transplantation

Aktive Filter

Suchergebnisse filtern